Please use this identifier to cite or link to this item:
|Title:||Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.||Austin Authors:||Enjeti, Anoop K;Agarwal, Rishu ;Blombery, Piers;Chee, Lynette;Chua, Chong Chyn ;Grigg, Andrew P ;Hamad, Nada;Iland, Harry;Lane, Steven;Perkins, Andrew;Singhal, Deepak;Tate, Courtney;Tiong, Ing Soo;Ross, David M||Affiliation:||Australasian Leukaemia and Lymphoma Group, Australia..
Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia..
New South Wales Health Pathology, John Hunter Hospital New Lambton Heights, NSW, Australia..
University of Newcastle, Callaghan, NSW, Australia..
Department of Clinical Haematology, The Royal Melbourne Hospital, Vic, Australia..
Peter MacCallum Cancer Centre, Melbourne, Vic, Australia..
Department of Medicine, The University of Melbourne, Parkville, Vic, Australia..
Department of Clinical Haematology, Northern Hospital, Melbourne, Vic, Australia..
Department of Haematology, St Vincent's Hospital School of Medicine, University of Notre Dame, NSW, Australia..
St Vincent's Clinical School Sydney, University of New South Wales, NSW, Australia..
Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia..
Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia..
Cancer Program, QIMR Berghofer Medical Research Institute Brisbane, Qld, Australia..
Head of Genomic Medicine, Alfred Health, Melbourne, Vic, Australia..
Haematology Directorate, SA Pathology and Royal Adelaide Hospital, Adelaide, SA, Australia..
Department of Clinical Haematology, Princess Alexandra Hospital, Queensland Health, Brisbane, Qld, Australia..
University of Queensland, Qld, Australia..
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia..
Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Vic, Australia..
Monash University, Melbourne, Vic, Australia..
Department of Haematology, Flinders University and Medical Centre, Adelaide, SA, Australia..
|Issue Date:||Jun-2022||metadata.dc.date:||2022||Publication information:||Pathology 2022; 54(4): 389-398||Abstract:||This review aims to provide an expert consensus statement to address the role of gene-panel testing in the diagnosis, prognosis and management of adult myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes (MDS/MPN) in Australia. This consensus statement was developed by an expert group, actively involved in gene panel testing in the area of MDS/MPN in Australia. This work was led by the chairs of the MDS (A/Prof A. Enjeti) and MPN (A/Prof D. Ross) working parties of the Australasian Leukaemia and Lymphoma Group (ALLG). The authors were selected after an expression of interest process on the basis of active laboratory involvement in gene panel testing, a specific demonstrated interest in MDS/MPN and/or publication record in this field. The authors were then allocated sections for literature review to identify the specific genes of interest for each MDS/MPN entity. At least two authors reviewed each section and an overarching diagnostic algorithm was developed by a consensus amongst all authors.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/30350||DOI:||10.1016/j.pathol.2022.03.002||ORCID:||0000-0002-2162-3288
|PubMed URL:||35461716||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35461716/||Type:||Journal Article||Subjects:||Myelodysplasia
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.